Table S1. Characteristics of human islet preparation used in this study. Donor Islet Viability Islet Purity Islet Size Average Islet Size Number #1 80 % 80 % 50-400 µm 100-200 µm Number #2 80 % 80 % 50-400 µm 100-200 µm Number #3 88 % 88 % 50-400 µm 100-200 µm Number #4 90 % 70 % 50-400 µm 100-200 µm Number #5 95 % 90 % 50-400 µm 100-200 µm Number #6 95 % 90 % 50-400 µm 100-200 µm
. Homogeneous GFP expression through human islets subsequent to transduction using the optimized protocol. Co-immunostaining of GFP (green), insulin (red) and glucagon (cyan) was performed on sections from Affi-Gel bead-embedded human pancreatic islets subsequent to treatment. Nuclei were stained with DAPI. Images were captured in samples fixed at 4 days post-infection using confocal microscopy. Scale-bars 50µm. n=3 per condition.
